Tech Company Financing Transactions

AGTC Funding Round

AGTC secured a $11.8 million venture capital round on 5/1/2009. Investors included InterWest Partners, Intersouth Partners and MedImmune Ventures.

Transaction Overview

Company Name
AGTC
Announced On
5/1/2009
Transaction Type
Venture Equity
Amount
$11,800,000
Round
Undisclosed
Investors

InterWest Partners (Lead Investor) (Christopher Ehrlich)

Intersouth Partners

MedImmune Ventures (Franklin Top)

Proceeds Purpose
The investment funds will be used by AGTC to complete the next phase in human clinical trials for its gene therapy treatments for Alpha-1 Antitrypsin Deficiency, a form of emphysema and Leber's Congenital Amaurosis (LCA) a form of childhood blindness.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
14193 NW 119th Ter. 10
Alachua, FL 32615
USA
Phone
(386) 462-2204
Website
www.agtc.com
Email Address
[email protected]
Overview
AGTC is developing cures for rare lung and eye diseases, offering hope to patients with unmet medical needs.
Profile
AGTC LinkedIn Company Profile
Social Media
AGTC Company Twitter Account
Company News
AGTC News
Facebook
AGTC on Facebook
YouTube
AGTC on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sue Washer
  Sue Washer LinkedIn Profile  Sue Washer Twitter Account  Sue Washer News  Sue Washer on Facebook
Chief Financial Officer
William Sullivan
  William Sullivan LinkedIn Profile  William Sullivan Twitter Account  William Sullivan News  William Sullivan on Facebook
Chief Medical Officer
Theresa Heah
  Theresa Heah LinkedIn Profile  Theresa Heah Twitter Account  Theresa Heah News  Theresa Heah on Facebook
Chief Scientific Officer
Mark Shearman
  Mark Shearman LinkedIn Profile  Mark Shearman Twitter Account  Mark Shearman News  Mark Shearman on Facebook
VP - Bus. Development
Matthew Feinsod
  Matthew Feinsod LinkedIn Profile  Matthew Feinsod Twitter Account  Matthew Feinsod News  Matthew Feinsod on Facebook
VP - Bus. Development
Stephen Potter
  Stephen Potter LinkedIn Profile  Stephen Potter Twitter Account  Stephen Potter News  Stephen Potter on Facebook
VP - General Counsel
Brian Krex
  Brian Krex LinkedIn Profile  Brian Krex Twitter Account  Brian Krex News  Brian Krex on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/1/2009: Patient Engagement Systems venture capital transaction
Next: 5/4/2009: eDataSource venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.